EFFICACY AND SAFETY OF BIOLOGICAL TREATMENT FOR INFLAMMATORY BOWEL DISEASE IN ELDERLY PATIENTS: RESULTS FROM A GETECCU COHORT.
Ferrer CS, Gismero FM, Caballol B, Ballester MP, Rey IB, García AC, Bautista JM, Chumillas RS, Benitez JM, Delgado LS, García AL, de Celix CR, Abreu IA, Melcarne L, Santos RP, Camí MM, Mateos AC, Díez CG, Calafat M, Galan HA, Vilaamil PV, Senosiain BC, Moya AG, Rodriguez Diaz CY, Spicakova K, Marcos NM, Molina G, Castro Parga L, Angulo AR, Del Campo LC, Rodriguez Grau MDC, Ramirez F, Pastrana BG, Partida IG, Mateu BB, Gonzalez EP, Iyo E, Gonzalez AE, Arnau ES, Villalba LH, Galindo PP, Medina LT, Alonso SM, Olmos Perez JA, Sadornil CD, Ramirez LG, Martín-Arranz MD, Sanroman AL, Fernández A, Murgui VM, Suárez CC, Florez P, Lobato Matilla ME, Sicilia B, Escribano PS, Martin CM, Mañosa M, De Acosta MB; On belhaf of Young group of GETECCU.
Ferrer CS, et al. Among authors: medina lt.
Gastroenterol Hepatol. 2024 May 4:502197. doi: 10.1016/j.gastrohep.2024.502197. Online ahead of print.
Gastroenterol Hepatol. 2024.
PMID: 38710465
English, Spanish.